中国银行 reported revenue of ¥356.90B for the period ended 2026-06-30, +8.5% year on year. Net income was ¥132.03B, a 37.0% net margin on a 100.0% gross margin. The largest revenue line is 个人金融业务 at 39% of the total. Free cash flow for the period was ¥303.40B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥356.90B | +8.5% |
| Gross profit | ¥356.90B | — |
| Operating income | ¥162.61B | — |
| Net income | ¥132.03B | +4.7% |
| Gross margin | 100.0% | Net margin 37.0% |
| Revenue Q/Q | -0.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 个人金融业务 | ¥139.62B | 39.1% |
| 公司金融业务 | ¥135.51B | 38.0% |
| 资金业务 | ¥50.05B | 14.0% |
| 保险业务 | ¥15.26B | 4.3% |
| 其他业务 | ¥14.28B | 4.0% |
| 投资银行业务 | ¥4.64B | 1.3% |
| 抵销 | ¥-2.45B | -0.7% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | ¥83.63B | 23.4% |
| Tax & other | ¥30.58B | 8.6% |
| Item | Amount |
|---|---|
| Total assets | ¥40,186.35B |
| Total liabilities | ¥36,945.97B |
| Shareholders' equity | ¥3,240.38B |
| Equity / assets | 8.1% |
| Operating cash flow | ¥319.59B |
| Capital expenditure | ¥16.20B |
| Free cash flow | ¥303.40B |
| Cash conversion (OCF / net income) | 391% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中金公司 ・ 中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies